Clinical trialNCT00614640WithdrawnPhase 1/PHASE2Interventional

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment0HIV Infections

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The therapeutic DNA vaccine, DermaVir, represents an immunization strategy that targets lymph node dendritic cells. Because of the high percentage of naive CD4 cells in children and adolescents, the potential for effective new HIV-specific CD4 cell responses may be more achievable in children than in adults. The primary purpose of this study is to evaluate the safety and tolerability of DermaVir in children and young adults.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Elizabeth McFarland, MD
University of Colorado Health Sciences Ctr.
Study Chair
clinicaltrials.gov ↗
Hans M.L. Spiegel, MD
George Washington University School of Medicine
Study Chair
clinicaltrials.gov ↗
Ram Yogev, MD
CMRC Children's Memorial Hospital
Study Chair
clinicaltrials.gov ↗
Willaim Borkowsky, MD
NYU Langone Health
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DermaVir patchPlacebo patch

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: —
Primary completion: 30 Nov 2013
Completion: —
Last update posted: 1 Nov 2021
Registered enrollment: 0
Registry id: NCT00614640

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.